GENOTYPE MARKERS AND PROTOONCOGENE ANALYSIS IN THE CD30-POSITIVE MALIGNANT HISTIOCYTOSIS DEL CELL-LINE WITH T(5-6)(Q35-P21)

被引:14
作者
GOGUSEV, J [1 ]
BARBEY, S [1 ]
NEZELOF, C [1 ]
机构
[1] HOP NECKER ENFANTS MALAD,PATHOL PEDIAT GRP,F-75743 PARIS 15,FRANCE
关键词
D O I
10.1002/ijc.2910460120
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The DEL cell line isolated from a patient who died of malignant histiocytosis exhibits a reciprocal chromosomal translocation t(5;6) (5q35;6p21). The cells were analyzed for lg(Jh), TCR β‐gene rearrangements and proto‐oncogene expression pattern, using a panel of molecularly cloned probes that in cluded c‐fms, c‐myc, c‐myb, c‐pim, c‐fos, N‐myc, c‐sis, c‐fgr as well as the virally derived probes v‐ki‐ras and v‐src. Consistent levels of expression of c‐fms, c‐myc, c‐myb, c‐ki‐ras and c‐fgr were identified in cells from several in vitro passages as well as from the heterotransplanted tumors in nude mice. Transcripts homologous to the c‐fos, c‐src and c‐sis were not observed. Southern blot study of DNA showed that the banding pattern of the screened proto‐oncogenes was not altered. Furthermore, Southern blot analysis demonstrated monoallelic immunoglobulin heavy chain (IgJh) rearrangement but a normal germ‐line configuration of the K light chain and TCR β‐genes. These results appear to imply that a T‐ or B‐cell origin can be eliminated and that several activated protooncogenes, usually expressed in immature MPS cells (c‐fms) and myeloblastic cells (c‐fgr), may be implicated in the proliferative activity of the DEL cell line, the stem of which may be a primitive, ancestral myelomonocytic cell. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:106 / 112
页数:7
相关论文
共 62 条
[31]  
Maniatis T, 1982, MOL CLONING LABORATO
[32]  
MASON DY, 1990, BRIT J HAEMATOL, V74, P161
[33]  
MORGAN R, 1989, BLOOD, V73, P2155
[34]  
MORGAN R, 1986, NEW ENGL J MED, V314, P1322
[35]   LOCALIZATION OF THE HUMAN PIM ONCOGENE (PIM) TO A REGION OF CHROMOSOME-6 INVOLVED IN TRANSLOCATIONS IN ACUTE LEUKEMIAS [J].
NAGARAJAN, L ;
LOUIE, E ;
TSUJIMOTO, Y ;
ARRUSHDI, A ;
HUEBNER, K ;
CROCE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2556-2560
[36]   EXPRESSION OF THE FGR PROTOONCOGENE PRODUCT AS A FUNCTION OF MYELOMONOCYTIC CELL MATURATION [J].
NOTARIO, V ;
GUTKIND, JS ;
IMAIZUMI, M ;
KATAMINE, S ;
ROBBINS, KC .
JOURNAL OF CELL BIOLOGY, 1989, 109 (06) :3129-3136
[37]   GENOTYPIC ANALYSIS OF LARGE CELL LYMPHOMAS WHICH EXPRESS THE KI-1 ANTIGEN [J].
OCONNOR, NTJ ;
STEIN, H ;
GATTER, KC ;
WAINSCOAT, JS ;
CRICK, J ;
ALSAATI, T ;
FALINI, B ;
DELSOL, G ;
MASON, DY .
HISTOPATHOLOGY, 1987, 11 (07) :733-740
[38]   HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN GENES - EVOLUTIONARY COMPARISONS OF C-UPSILON, C-DELTA AND C-GAMMA GENES AND ASSOCIATED SWITCH SEQUENCES [J].
RABBITTS, TH ;
FORSTER, A ;
MILSTEIN, CP .
NUCLEIC ACIDS RESEARCH, 1981, 9 (18) :4509-4524
[39]  
Rappaport H., 1966, ATLAS TUMOR PATHOLOG
[40]   EXPRESSION OF THE HUMAN C-FMS PROTOONCOGENE PRODUCT (COLONY-STIMULATING FACTOR-I RECEPTOR) ON PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND CHORIOCARCINOMA CELL-LINES [J].
RETTENMIER, CW ;
SACCA, R ;
FURMAN, WL ;
ROUSSEL, MF ;
HOLT, JT ;
NIENHUIS, AW ;
STANLEY, ER ;
SHERR, CJ .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1740-1746